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In somatic cells DNA topoisomerase 11 (topo 11) is 
thought to be involved in the domain organization of the 
genome by anchoring the basis of chromatin loops to a 
chromosomal scaffold. Lampbrush chromosomes of am-
phibian oocytes directly display this radial loop organi-
zation in cytological preparations. In order to find out 
whether topo 11 may play a role in the organization of 
these meiotic chromosomes, we performed immunofluo-
rescence studies using antibodies against Xenopus topo 
11. Our results indicate that topo 11 is apparently absent 
from lampbrush chromosomes and is hence unlikely to 
act as a "fastener" of the numerous lateral chromo-
somalloops. Topo 11 was, however, enriched in the am-
plified nucleoli of Xenopus oocytes. © 1993 Academic Press, Inc. 
INTRODUCTION 
The chromatin fiber of eukaryotic cells is folded into a 
series of loops or domains which are stabilized by a 
structural framework called nuclear matrix or chromo-
somal scaffold. The loops are thought to be anchored at 
their base to the matrix or scaffold via specific attach-
ment sites, the so-called matrix or scaffold attachment 
regions (MARs or SARs). Loop length is variable, rang-
ing from 5 to 200 kbp of DNA [for reviews see 1, 2]. 
Unfortunately, the chromatin loop structures cannot be 
directly visualized in interphase nuclei with cytological 
methods because the chromatin strands are highly en-
tangled. 
The situation is different for amphibian lampbrush 
chromosomes which can be readily examined under al-
most native conditions by light microscopy [3]. The 
structural organization of these meiotic chromosomes 
exhibits a striking similarity to the loop model described 
above. Each lampbrush chromosome consists of a chro-
mosomal axis from which numerous loops radiate lat-
erally. The axis represents a linear array of chromo-
1 To whom correspondence and reprint requests should be ad-
dressed at Zoologie I, Biozentrum Am Hubland, D-97074 Wiirzburg, 
Germany. Fax: 0049 931 888 4252. 
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meres containing highly condensed chromatin, while 
the lateral loops consist of decondensed, transcription-
ally active chromatin covered with numerous nascent 
transcripts. Because lampbrush chromosome architec-
ture resembles so closely the proposed organization of 
somatic interphase chromatin and mitotic chromo-
somes, it is tempting to speculate that the same molecu-
lar components might be involved in the maintenance of 
chromatin loops. 
One of the best characterized components of the chro-
mosomal scaffold is DNA topoisomerase 11 (topo 11) [4-
7]. Besides its enzymatic activity that creates transient 
double-strand breaks in duplex DNA and passes DNA 
strands through one another, the protein has been 
shown to interact with the MAR and SAR elements [8]. 
Thus, topo 11 is thought to have catalytic as well as struc-
tural functions. Topo 11 is not only associated with the 
scaffold of mitotic chromosomes but also the cores and 
centromeric regions of spermatocyte-derived meiotic 
chromosomes [9]. Recently Luke and Bogenhagen iden-
tified by biochemical means topo 11 in the germinal vesi-
cles of Xenopus oocytes [10]. These findings prompted 
us to study the localization of topo 11 in Xenopus ger-
minal vesicles in order to find out whether it is asso-
ciated with lampbrush chromosomes and hence could 
play a role in maintaining the higher-order structure of 
these particular chromosomes. 
MATERIAL AND METHODS 
Animals. Female Xenopus laevis were purchased from the South 
African Snake Farm (Fish Hoek, Cape Province, South Africa). 
Antibodies. The rabbit-derived antiserum against Xenopus topo 
11 has been described in detail [10]. Antiserum and preimmune serum 
were generously provided by Dr. D. Bogenhagen (Stony Brook, New 
York). 
Immunofluorescence microscopy. Xenopus A6 cells were grown on 
coverslips as described elsewhere [11], rinsed with PBS, fixed with 
methanol (10 min, -20°C) followed by acetone (5 min, -20°C) and 
finally air-dried. 
Cryostat sections (5 I'm) of shock-frozen Xenopus ovary were air-
dried, fixed in 1% formaldehyde in PBS (15 min), and rinsed with PBS. 
Xenopus oocytes were staged according to Dumont [12]. Lamp-
brush chromosomes were prepared following the protocol described 
by Callan et al. [13]. After fixation in 70% ethanol, slides were trans-
ferred into PBS. 
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Cells, cryostat sections, or lampbrush chromosome preparations 
were incubated with antiserum against topo II or corresponding 
preimmune serum (1:200 diluted in PBS) for 30 min at room tempera-
ture. After three washes in PBS, secondary antibodies were added 
(FITC-conjugated goat anti-rabbit immunoglobulins; Dianova, Ham-
burg, Germany; diluted 1:100 in PBS). After an incubation time of30 
min at room temperature slides or coverslips were again washed in 
PBS and finally mounted in "antifade" [14] supplemented with the 
DNA-staining fluorescent dye Hoechst 33258 (final concentration, 5 
Ilg/ml). 
Photographs were taken with a Zeiss Axiophot (Carl Zeiss, Oberko-
chen, Germany) equipped with epifluorescence optics and the appro-
priate filter sets. 
Gel electrophoresis and immunoblotting. Proteins were resolved by 
SDS-PAGE [15] using 6% acrylamide in the separating gel. For im-
munoblots, proteins were transferred to nitrocellulose [16]. The 
membrane was blocked with 5% nonfat dry milk in TBS (10 mM 
Tris/HCI, pH 7.4, 150 mM NaCI) and incubated with topo II-specific 
antiserum (diluted 1:20,000 in blocking buffer) for 1 h. After three 
washes in TBS, secondary antibodies (alkaline phosphatase-conju-
gated anti-rabbit IgG; Promega, Heidelberg, Germany) were added at 
1:10,000 dilution in blocking buffer. After three washes in TBS, detec-
tion of bound antibodies was performed using nitro blue tetrazolium 
chloride and 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt 
(Biomol, Hamburg, Germany) as chromogenic substrates. 
Egg extract and quantitation of protein. Xenopus egg extract was 
prepared according to Newport [17] . Protein was quantified as de-
scribed by Bradford [18]. 
RESULTS 
Immunoblotting Analyses 
The topo II-specific antiserum has been reported to 
react with an 180-kDa oocyte protein in immunoblot-
ting analysis [10]. Since at least two different isoforms 
of topo II (170 and 180 kDa) have been identified by 
molecular cloning [19], drug inhibition studies [20], or 
immunological approaches involving monoclonal anti-
bodies [21], it was of interest to find out whether the 
polyclonal antiserum directed against the 180-kDa form 
of oocyte topoisomerase II also reacted with the 170-
kDa form or other variants of the enzyme. For this pur-
pose proteins of Xenopus germinal vesicles, egg extract, 
or cultured epithelial cells (harvested during logarith-
mic phase of growth) were separated by gel electrophore-
sis, transferred to nitrocellulose, and probed with the 
topo II-specific antiserum (Fig. 1). As already observed 
by Luke and Bogenhagen [10], the major immunoreac-
tive protein present in Xenopus eggs had a slightly re-
duced mobility in SDS-PAGE as compared to oocyte 
topo II. In contrast, the immunoreactive protein of Xen-
opus A6 cells migrated faster (with an apparent molecu-
lar mass of 170 kDa) than the oocyte topo II (Fig. 1, 
lanes 1 and 3). Proteins visible in the lower molecular 
weight range were stained nonspecifically as judged 
from control blots using the corresponding preimmune 
serum (not shown). We conclude that the antiserum 
used in this study recognizes both the 170- and the 180-
kDa form of Xenopus topo II. 
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FIG. 1. Immunoblots of isolated oocyte nuclei, eggs, and somatic 
Xenopus cells with the topo II -specific antiserum. Proteins of 20 Xen-
opus oocyte nuclei (lane 1), egg extract (50 Ilg protein) (lane 2), and 2 
X 106 A6 cells (lane 3) were separated by SDS-PAGE, transferred to 
nitrocellulose, and probed with the anti-topo II antiserum. In isolated 
oocyte nuclei and total egg extract, the antibodies bind to a single 
polypeptide of 180- or 182-kDa, respectively, whereas in A6 cells the 
immunoreactive protein has an apparent molecular mass of 170 kDa. 
Molecular masses of the reference proteins are indicated in kDa. 
Localization of Topo II in Cultured Xenopus A6 Cells 
Since the antiserum against Xenopus topo II had so 
far only been used for immunoprecipitation and West-
ern blot analyses [10], we first had to find out whether 
these antibodies could also be used for immunofluores-
cence experiments. Incubation of methanol/acetone-
fixed Xenopus A6 cells with the antiserum against topo 
II resulted in a very complex immunofluorescence pat-
tern (Fig. 2). As expected, mitotic chromosomes were 
intensely labeled (Fig. 2a, arrow). In agreement with ear-
lier studies [6, 22], interphase nuclei were variably 
stained with the anti-topo II antibodies. While some nu-
clei were completely negative, others showed a finely 
punctate fluorescence throughout the nucleoplasm. In 
addition, the antibodies stained the nucleoli intensely. 
Asjudged from the immunofluorescence signal, the rela-
tive proportion of nucleolar and extranucleolar topo II 
appeared to be quite variable in different cells, probably 
depending on their specific growth stage. Preimmune 
serum caused only a general fluorescence background 
reaction. Since our results obtained with Xenopus A6 
cells were consistent with the distribution of topo II de-
scribed in other cells and with othertopo II-specific anti-
bodies [6,21-23], we extended the immunofluorescence 
approach to study the subcellular localization of topo II 
in Xenopus oocytes. 
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FIG. 2. Immunofluorescence localization of topo 11 on Xenopus 
A6 cells. Cells were grown on coverslips and stained with antiserum 
against topo 11. 'Rhe resulting fluorescence pattern (a) is heteroge-
neous: Some nuclei are completely negative, some reveal an uniform 
punctate staining and some a nucleoplasmic plus strong nucleolar 
staining. Mitotic chromosomes are intensely labeled (arrow in a). The 
corresponding Hoechst staining (b) and phase-contrast images (c) are 
shown. Bar: 20 /Lm. 
Localization of Topo II in Nuclear Structures of 
Xenopus Oocytes 
As had been shown by Luke and Bogenhagen [10], 
nuclei of stage V-VI oocytes contain larger amounts of 
topo II compared to earlier oocyte stages. Therefore, we 
first examined lampbrush chromosomes prepared from 
large oocytes. In no case we could detect any significant 
labeling of the lampbrush chromosomes (Fig. 3a). A 
faint fluorescence of their axes was also seen with the 
corresponding preimmune serum and therefore consid-
ered to be nonspecific (Fig. 3b). In contrast, the internal 
component of the amplified nucleoli reacted strongly 
with the topo ll-specific antiserum (Fig. 3a). Lamp-
brush chromosomes isolated from growing oocytes 
(stage Ill-IV) were also negative with the topo II anti-
serum (Fig. 3c). In these specimens, however, the fluo-
rescence intensity of the amplified nucleoli was much 
weaker as compared to those prepared from full-grown 
oocytes (Fig. 3c). 
Since it is conceivable that topo II might be extracted 
during the chromosome isolation procedure (see Dis-
cussion), frozen sections of Xenopus ovary were fixed 
with formaldehyde and processed for immunofluores-
cence microscopy. The staining pattern was essentially 
identical to that observed with the spread chromosome 
preparations. The numerous amplified nucleoli of full-
grown oocytes fluoresced whereas the lampbrush chro-
mosome portions included in the section were negative 
(data not shown) . 
DISCUSSION 
The antiserum against the 180-kDa topo 11 used in 
this study had already been characterized in detail [10]. 
It neutralized decatenation activity in egg extracts and 
reacted in immunoblots with an oocyte protein of ap-
proximately 180 kDa. The content of topo 11 increased 
throughout oogenesis from 0.006 ng in a stage I oocyte 
to 1.44 ng in a stage VI oocyte with a maximum amount 
of 3 ng/egg. Luke and Bogenhagen [10] observed that 
the major band of egg topo II had a slightly reduced 
mobility in SDS-PAGE compared to the oocyte en-
zyme. Our immunoblotting data confirm this result and, 
furthermore, reveal that the antiserum raised against 
the 180-kDa isozyme of topo II is also crossreacting with 
a 170-kDa form present in Xenopus A6 cells. 
The antiserum against Xenopus 180-kDa topo 11 is 
suitable for immunofluorescence studies. In Xenopus 
A6 cells, mitotic chromosomes and some of the inter-
phase nuclei and nucleoli are stained. Our finding that a 
subpopulation of the A6 cells did not react with the an-
tibody is in agreement with the results of Earnshaw and 
colleagues [6, 22] who reported that the topo 11 content 
of nuclei varies during the cell cycle. They observed that 
in G 1 phase some of the nuclei were negative for topo II. 
A nucleolar localization oftopo II in HeLa cells was also 
reported by Negri et al. [21]. Using monoclonal antibod-
ies these authors provided evidence for the existence of 
two immunologically distinguishable isoforms of to po II 
with different nuclear locations: a 180-kDa form asso-
ciated with the nucleoli and a 170-kDa form present in 
the nucleoplasm. While the latter form was more abun-
dant during logarithmic phase of growth, the 180-kDa 
isoform occurred preferentially during the plateau 
phase of growth. Recently, however, using polyclonal 
antisera, Petrov and colleagues [23] observed both iso-
forms in the nucleoplasm and the nucleolus. Anyhow, 
since the antiserum used in this study recognizes the 
170- and the 180-kDa form of to po II, it is not difficult to 
explain that we observed both, a nucleolus-associated as 
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FIG. 3. Immunofluorescence localization of topo II on spread Xenopus lampbrush chromosomes and amplified nucleoli. Spread nuclear 
contents of stage VI (a,b) or stage IV (c) oocytes were incubated with topo II antiserum (a,c) or corresponding preimmune serum (b). Positive 
fluorescence is seen exclusively in the amplified nucleoli of mature oocytes, in particular in their inner regions (a), which appear as dense cores 
in phase contrast (arrows in a"). The corresponding Hoechst staining is shown in a'-c'. Bar: 20 I'm. 
well as a nucleoplasmic fluorescence in cultured Xeno-
pus A6 cells. 
Using immunofluorescence microscopy we were un-
able to detect topo 11 on lampbrush chromosomes pre-
pared from full-grown oocytes known to contain a large 
store of to po 11. However, the topo II-specific antiserum 
labeled strongly the internal component ("nucleolar 
core") of the amplified nucleoli which contains the 
rRNA genes [24]. Antibodies directed against RNA poly-
merase I produced essentially the same immunofluores-
cence pattern (data not shown). These findings could be 
explained by any of the following considerations. 
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1. Since previous studies provided evidence for an en-
richment oftranscriptionally active genes in the nuclear 
matrix fraction [25, 26], it might be argued that topo 11 
is associated with lampbrush chromosomes only when 
they are transcribed at maximal rates, i.e., in growing 
oocytes. We therefore prepared lampbrush chromo-
somes also from stage IV oocytes. Despite the presence 
of numerous lateral loops indicative of ongoing tran-
scription, these chromosomes turned out to be negative 
for topo 11 as well. 
2. Topo 11 is associated with lampbrush chromo-
somes but not accessible to the antibodies. Although we 
cannot formally exclude this possibility, we consider it 
quite unlikely. Antibodies directed against chromatin 
constituents such as the core histones [27-29] and DNA 
[30] label the axis of the lampbrush chromosomes 
strongly, thus indicating that the specific chromomere 
organization does not exclude antibody binding. Fur-
thermore, topo 11 is readily detectable on metaphase 
chromosomes of somatic cells despite their highly com-
pact chromatin conformation. 
3. Topo 11 is associated with lampbrush chromo-
somes in vivo but is lost during the isolation procedure. 
In fact, it has been recently shown that topo 11 is readily 
dissociated from mitotic chromosomes assembled in 
Xenopus egg extract under almost physiological salt 
conditions (50-100 mM NaCl) [31]. We therefore pre-
pared lampbrush chromosomes under conditions that 
should minimize this potential artifact. Immediately 
after tearing off the nuclear envelope, the chromosomes 
were centrifuged for only 5 min and then fixed in 70% 
ethanol. Alternatively, fixation was performed with 
methanol following the procedure for staining tissue 
culture cells. Since copper ions in a concentration as low 
as ID- 8 M have been reported to stabilize the chromo-
somal scaffold [32], we added 1 JlM CuCl2 into the 
spreading buffer. In no case topo 11 was detectable on 
lampbrush chromosomes. 
To exclude the possibility of topo 11 extraction during 
chromosome isolation and antibody incubation, we also 
prepared frozen sections of full-grown oocytes and fixed 
them immediately in formaldehyde prior to incubation 
with the anti-topo 11 antibodies. The only detectable 
fluorescent structures were the amplified nucleoli, 
whereas the portions of the lampbrush chromosomes 
included in the sections were negative. Taken together, 
our data argue that topo 11 is either absent from the 
lampbrush chromosomes or occurs at levels far below 
the topo 11 value of mitotic chromosomes [for quantita-
tive data see 7]. Thus, our results speak against an in-
volvement of topo 11 in the structural maintenance of 
lampbrush chromosomes. Similar results have been re-
cently obtained from studies of mitotic chromosomes 
assembled in vitro [31]. These authors showed that mi-
totic chromosomes retained their specific organization 
after extraction of topo 11. 
4. One could imagine that lampbrush chromosomes 
contain a topo II-like protein that is not recognized by 
the antibody used in our study. Although this cannot be 
ruled out completely, we consider this unlikely since the 
antiserum reacts with a 180- and a 170-kDa form oftopo 
11 and neutralizes all decatenation activity in egg ex-
tracts. Moreover, Xenopus egg extract depleted of topo 
11 (using the same antiserum as that in the present 
study) failed to convert chicken erythrocyte nuclei into 
condensed chromosomes. Upon readdition of purified 
topo 11, condensation activity was restored [33]. These 
results clearly demonstrate that immunologically dis-
tinct proteins with topo 11 activities are absent in Xeno-
pus eggs. 
5. Lampbrush chromosomes lack topo 11 but may 
contain other protein(s) involved in anchoring the lat-
eral loops to the chromosomal axis. A precedent for a 
distinct difference in molecular composition of oocyte 
lampbrush chromosomes and somatic chromosomes 
has recently been found. Although chromatin of the 
lampbrush chromosome axes is highly condensed, his-
tone HI seems to be absent [28]. Thus, in spite of the 
striking similarity of lampbrush chromosome morphol-
ogy and the loop model of somatic chromatin organiza-
tion, the molecular mechanisms underlying chromatin 
folding need not to be identical. Although negative out-
comes of immunocytochemical labeling experiments 
should be cautiously interpreted, we favor the view that 
topo 11 is in fact absent from lampbrush chromosomes. 
The question remains: What is the function of topo 11 
associated with the amplified nucleoli in full-grown 
Xenopus oocytes? As has been shown in several experi-
mental systems, topo 11 is essential for chromosome 
condensation and segregation during mitosis as well as 
during meiosis [31,33-43]. It is one of the characteris-
tics of Xenopus development that during the early, rapid 
embryonic cleavages there is almost no transcriptional 
activity. Until the midblastula transition the embryo is 
therefore dependent on maternally stored transcripts 
and proteins including topo 11 [44]. It remains to be elu-
cidated whether topo 11 bound to the amplified nucleoli 
represents a storage form of this enzyme for future em-
bryonic development and/or plays a direct role in the 
structural and functional organization of these nucleoli. 
The finding that topo 11 is also found enriched in nu-
cleoli of somatic cells [21,23] supports the view that it is 
a genuine component of nucleoli in general. 
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